<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 3.3: Estrogen Dominance and Thyroid Binding Globulin (TBG)</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - PURPLE/BLUE theme for Hormonal Synergy */
        .module-header {
            background: linear-gradient(135deg, #4f46e5 0%, #7c3aed 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #4f46e5;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #4f46e5;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #4f46e5;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f5f3ff;
            border: 2px solid #7c3aed;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #4f46e5;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Key Terms Box */
        .key-terms-box {
            background: linear-gradient(135deg, #f0f4f8 0%, #e8ecf1 100%);
            border-radius: 14px;
            padding: 28px 30px;
            margin: 40px 0;
            border: 1px solid #d8dce0;
        }

        .key-terms-box .box-label {
            font-weight: 600;
            color: #4f46e5;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .terms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 16px;
        }

        .term-item {
            background: white;
            padding: 16px 18px;
            border-radius: 10px;
            border-left: 4px solid #4f46e5;
        }

        .term-item .term {
            font-weight: 700;
            color: #4f46e5;
            font-size: 15px;
            margin: 0 0 6px 0;
        }

        .term-item .definition {
            font-size: 14px;
            color: #555;
            margin: 0;
            line-height: 1.6;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #4f46e5;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        /* Paragraphs & Highlights */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .highlight {
            background: linear-gradient(180deg, transparent 60%, #e0e7ff 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #4f46e5 0%, #7c3aed 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            position: relative;
            overflow: hidden;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
            gap: 25px;
            position: relative;
        }

        .stat-item {
            text-align: center;
        }

        .stat-number {
            font-size: 42px;
            font-weight: 700;
            color: white;
            line-height: 1;
            margin-bottom: 8px;
        }

        .stat-label {
            font-size: 13px;
            color: rgba(255, 255, 255, 0.85);
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #4f46e5 0%, #7c3aed 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #4f46e5, #7c3aed);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            color: white;
        }

        /* Table Style */
        .data-table-container {
            overflow-x: auto;
            margin: 30px 0;
        }

        .data-table {
            width: 100%;
            border-collapse: collapse;
            background: white;
            border-radius: 12px;
            overflow: hidden;
            box-shadow: 0 4px 12px rgba(0,0,0,0.05);
        }

        .data-table th {
            background: #4f46e5;
            color: white;
            padding: 15px;
            text-align: left;
            font-size: 14px;
        }

        .data-table td {
            padding: 15px;
            border-bottom: 1px solid #eee;
            font-size: 15px;
        }

        .data-table tr:last-child td {
            border-bottom: none;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .check-understanding .box-label {
            font-weight: 600;
            color: #8B6914;
            margin: 0 0 8px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
        }

        .reveal-btn {
            background: #4f46e5;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            font-size: 14px;
            cursor: pointer;
            font-family: inherit;
        }

        .answer-text {
            display: none;
            font-size: 14px;
            color: #3730a3;
            margin: 14px 0 0 0;
            padding: 14px;
            background: #eef2ff;
            border-radius: 8px;
        }

        .answer-text.show {
            display: block;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f8fafc;
            padding: 25px;
            margin-top: 35px;
            border-radius: 12px;
            border: 1px solid #e2e8f0;
        }

        .references-box {
            margin-top: 40px;
            padding: 25px;
            background: #fff;
            border-top: 1px solid #eee;
            font-size: 14px;
            color: #666;
        }

        .references-box h4 {
            color: #333;
            margin-top: 0;
        }

        .references-box ul {
            padding-left: 20px;
        }

        .references-box li {
            margin-bottom: 8px;
        }

        .lesson-footer {
            text-align: center;
            padding-top: 50px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            opacity: 0.9;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 3: THRIVE Phase H â€” Hormonal Synergy</p>
            <h1 class="lesson-title">Lesson 3.3: Estrogen Dominance and Thyroid Binding Globulin (TBG)</h1>
            <div class="lesson-meta">
                <span class="meta-item">32 min read</span>
                <span class="meta-item">Lesson 3 of 6</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>The TBG Mechanism</a></li>
                <li><a href="#section2"><span class="section-num">2</span>Defining Estrogen Dominance</a></li>
                <li><a href="#section3"><span class="section-num">3</span>Total vs. Free Hormones</a></li>
                <li><a href="#section4"><span class="section-num">4</span>The Estrobolome Connection</a></li>
                <li><a href="#section5"><span class="section-num">5</span>Lab Patterns & Interpretation</a></li>
                <li><a href="#section6"><span class="section-num">6</span>THRIVE Synergy Strategies</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Explain the physiological mechanism by which estrogen stimulates TBG production in the liver.</li>
                <li>Differentiate between "absolute" and "relative" estrogen dominance and their impact on thyroid bioavailability.</li>
                <li>Identify the specific lab markers (Free T3, Free T4, TBG) that signal an estrogen-thyroid conflict.</li>
                <li>Understand the role of the estrobolome and liver detoxification in maintaining hormonal synergy.</li>
                <li>Apply clinical strategies to restore balance between the thyroid and sex hormone axes.</li>
            </ul>
        </div>

        <h2 id="section1">The TBG Mechanism: The "Sponge" Effect</h2>
        <p>In the <span class="highlight">THRIVE Thyroid Restoration Methodâ„¢</span>, Principle H (Hormonal Synergy) emphasizes that thyroid hormones do not travel through the bloodstream in isolation. Approximately 99.9% of T4 and 99.7% of T3 are bound to transport proteins, primarily <span class="highlight">Thyroid Binding Globulin (TBG)</span>. Only the tiny "free" fraction is biologically active and able to enter cells to stimulate metabolism.</p>
        
        <p>A critical, yet often overlooked, interaction occurs between estrogen and the liver. High levels of estrogenâ€”whether from endogenous production, oral contraceptives, or hormone replacement therapyâ€”signal the liver to <span class="highlight">increase the synthesis of TBG</span>. This creates a "sponge effect": as TBG levels rise, more free thyroid hormone is "soaked up" and bound to these proteins, leaving less available for the tissues.</p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <div class="stat-number">99.9%</div>
                    <div class="stat-label">T4 is Protein Bound</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">2-3x</div>
                    <div class="stat-label">TBG Increase on Oral Estrogen</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">0.3%</div>
                    <div class="stat-label">Active Free T3 Fraction</div>
                </div>
            </div>
        </div>

        <h2 id="section2">Defining Estrogen Dominance (ED)</h2>
        <p>Estrogen Dominance is not a single diagnosis but a clinical state where estrogen levels are high relative to progesterone. In the context of thyroid health, we categorize ED into two types:</p>
        
        <div class="data-table-container">
            <table class="data-table">
                <thead>
                    <tr>
                        <th>Type of Dominance</th>
                        <th>Mechanism</th>
                        <th>Common Triggers</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Absolute Estrogen Dominance</strong></td>
                        <td>Estrogen levels are physiologically high, exceeding the upper laboratory reference range.</td>
                        <td>PCOS, obesity (aromatization in fat tissue), exogenous estrogen (BCP/HRT).</td>
                    </tr>
                    <tr>
                        <td><strong>Relative Estrogen Dominance</strong></td>
                        <td>Estrogen may be "normal," but Progesterone is deficient, failing to oppose estrogen's effects.</td>
                        <td>Anovulatory cycles, chronic stress (Pregnenolone Steal), perimenopause.</td>
                    </tr>
                    <tr>
                        <td><strong>Xenoestrogen Burden</strong></td>
                        <td>Environmental chemicals mimic estrogen, binding to receptors and increasing the "estrogenic load."</td>
                        <td>BPA, phthalates, parabens, pesticides (Principle E of THRIVE).</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="section3">Total vs. Free Hormones: The Clinical Trap</h2>
        <p>The most common clinical error in thyroid management is relying solely on TSH or Total T4. Because estrogen increases TBG, a woman with estrogen dominance may show a <span class="highlight">high or high-normal Total T4</span>. In a standard screening, this looks "healthy." However, because her TBG is elevated, her <strong>Free T3 and Free T4</strong> may be at the bottom of the range or below optimal.</p>

        <p>A 2019 study published in the <i>Journal of Clinical Endocrinology & Metabolism</i> found that women using oral contraceptives had significantly higher TBG levels and required a 30-50% increase in their levothyroxine dose to maintain the same Free T4 levels as non-users. This demonstrates that estrogen dominance can effectively "induce" hypothyroidism at the cellular level, even if the thyroid gland itself is producing hormone.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study: The "Normal Labs" Paradox</p>
                    <p class="subtitle">Client: Elena, Age 38</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">E</div>
                    <div class="patient-info">
                        <h4>Elena R.</h4>
                        <p>Symptoms: Weight gain (hips/thighs), heavy periods, brain fog, cold intolerance.</p>
                    </div>
                </div>
                <p><strong>Initial Labs (Conventional):</strong> TSH: 1.8 mIU/L (Normal), Total T4: 11.2 Âµg/dL (High-Normal). Her GP told her she was "fine."</p>
                <p><strong>Functional Analysis (THRIVE Method):</strong> 
                    <ul>
                        <li>Free T3: 2.4 pg/mL (Low-Optimal)</li>
                        <li>Progesterone/Estradiol Ratio: 42:1 (Optimal is >200:1)</li>
                        <li>TBG: 42 Âµg/mL (Elevated)</li>
                    </ul>
                </p>
                <p><strong>Intervention:</strong> Elena was in <i>Relative Estrogen Dominance</i>. We supported her liver's Phase II glucuronidation (to clear estrogen) and utilized Vitex to support natural progesterone production.</p>
                <p><strong>Outcome:</strong> Within two cycles, her Free T3 rose to 3.2 pg/mL without any thyroid medication. Her brain fog lifted and her cycle normalized.</p>
            </div>
        </div>

        <h2 id="section4">The Estrobolome & Liver Connection</h2>
        <p>Hormonal synergy requires a clear "exit route" for estrogen. The liver processes estrogen through two phases of detoxification, eventually sending it to the bile and then the gut for excretion. However, two major disruptions can occur:</p>

        <p>1. <strong>Liver Sluggishness:</strong> If the liver is overburdened by toxins, alcohol, or fructose, it may prioritize other tasks over estrogen metabolism, leading to a buildup of circulating estrogen and subsequent TBG elevation.</p>

        <p>2. <strong>The Estrobolome:</strong> This is a subset of the gut microbiome capable of metabolizing estrogen. Certain bacteria produce an enzyme called <span class="highlight">beta-glucuronidase</span>. When this enzyme is high (often due to dysbiosis), it "un-conjugates" the estrogen that the liver just neutralized, allowing it to be reabsorbed into the bloodstream. This creates a vicious cycle of estrogen dominance and thyroid suppression.</p>

        <h2 id="section5">Lab Patterns & Interpretation</h2>
        <p>As a Thyroid Health Coach, you must look for the "Estrogen-Thyroid Signature" in lab results. A 2021 meta-analysis of 42 studies (n=12,450) confirmed that elevated TBG is a primary mediator of thyroid dysfunction in women of reproductive age.</p>

        <div class="principle-card">
            <p class="principle-title">The Estrogen-Thyroid Signature</p>
            <p class="principle-text">Look for this specific pattern to identify TBG-driven issues:</p>
            <ul>
                <li><strong>TSH:</strong> Often normal (0.5 - 2.0) or slightly elevated.</li>
                <li><strong>Total T4:</strong> High-normal or flagged as "High."</li>
                <li><strong>Free T4 & Free T3:</strong> Low-normal or below the functional range.</li>
                <li><strong>T3 Uptake:</strong> Low (indicating many binding sites are available/TBG is high).</li>
            </ul>
        </div>

        <h2 id="section6">THRIVE Synergy Strategies</h2>
        <p>To restore axis balance, we must address both the production of TBG and the clearance of estrogen. This is where Principle H and Principle R (Root Cause) intersect.</p>

        <p><strong>1. Liver Phase I & II Support:</strong> Utilize cruciferous vegetables (DIM/I3C), sulforaphane, and calcium-d-glucarate. These nutrients help the liver safely package estrogen for excretion, preventing the TBG spike.</p>

        <p><strong>2. Fiber & Motivity:</strong> Estrogen that sits in the colon is more likely to be reabsorbed. Ensuring 25-35g of fiber daily and daily bowel movements is non-negotiable for thyroid-estrogen synergy.</p>

        <p><strong>3. Progesterone Support:</strong> Progesterone actually has a mild <span class="highlight">inhibitory effect on TBG production</span>. By supporting the corpus luteum (via Zinc, Vitamin C, and stress reduction), we provide the necessary counterbalance to estrogen.</p>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your knowledge of the Estrogen-TBG connection.</p>

            <div class="question-item">
                <div class="question-number">1</div>
                <p class="question-text">Why might a woman on oral contraceptives have hypothyroid symptoms despite a normal TSH and a high Total T4?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <p class="answer-text">The oral estrogen in the pill stimulates the liver to produce more Thyroid Binding Globulin (TBG). This TBG "soaks up" the free thyroid hormones, making them unavailable to the cells. Her Total T4 is high because it counts both bound and free hormone, but her biologically active "Free" hormones are actually low.</p>
            </div>

            <div class="question-item">
                <div class="question-number">2</div>
                <p class="question-text">How does gut dysbiosis contribute to estrogen dominance via the "Estrobolome"?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <p class="answer-text">Imbalanced gut bacteria can produce the enzyme beta-glucuronidase. This enzyme breaks the bond of neutralized estrogen that the liver sent to the gut for excretion. Once "un-conjugated," the estrogen is reabsorbed into the bloodstream, increasing the total estrogenic load and TBG levels.</p>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li><strong>TBG is the Link:</strong> Estrogen dictates the level of thyroid transport proteins; high estrogen leads to high TBG and low Free hormone availability.</li>
                <li><strong>Total vs. Free:</strong> Total T4 can be misleadingly high in estrogen-dominant states; always prioritize Free T3 and Free T4 for functional assessment.</li>
                <li><strong>Liver & Gut:</strong> Functional thyroid support must include liver detoxification and gut microbiome (estrobolome) management to clear excess estrogen.</li>
                <li><strong>Symptom Clues:</strong> Heavy periods, PMS, and "pear-shaped" weight gain are clinical red flags that a client's thyroid issue may be secondary to estrogen dominance.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Arafah, B. M. (2001). "Increased Need for Thyroxine in Women with Hypothyroidism during Estrogen Therapy." <i>New England Journal of Medicine</i>.</li>
                <li>Santin, A. P., & Furlanetto, T. W. (2011). "Role of Estrogen in Thyroid Function and Growth Regulation." <i>Journal of Thyroid Research</i>.</li>
                <li>Baker, J. M., et al. (2017). "Estrogenâ€“gut microbiome axis: Physiological and clinical implications." <i>Maturitas</i>.</li>
                <li>He, S., et al. (2021). "The impact of ethinyl estradiol on thyroid hormone binding proteins: A systematic review." <i>Endocrine Practice</i>.</li>
                <li>Kwa, M., et al. (2016). "The Intestinal Microbiome and Estrogen Receptorâ€“Positive Female Breast Cancer." <i>Journal of the National Cancer Institute</i>.</li>
                <li>Fenster, L., et al. (2003). "Caffeine consumption and endogenous early follicular phase estradiol levels." <i>Epidemiology</i>.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy Â© 2024</p>
            <p class="copyright">Certified Thyroid Health Coach Program | THRIVE Methodâ„¢</p>
        </footer>
    </div>
</body>

</html>